Workflow
美容服务
icon
Search documents
过年变美“三件套”消费高峰将至,江苏省消保委提醒别踩坑
Xin Lang Cai Jing· 2026-01-11 11:01
转自:扬子晚报 三是价格不透明,宣传时标注低价基础款,实际消费时却以底胶另算、款式升级、甲片加价等名义叠加 隐性费用。 临近过年,美发、美甲、美睫等美容服务迎来消费高峰。近日,江苏省消保委提醒警惕过年"三件套"套 路,建议消费者理性充值,核查资质;商家诚信经营,保障安全。 图源 视觉 中国 "变美之旅"变成"闹心之旅" 消费纠纷 【下载黑猫投诉客户端】主要分四种情况 不少消费者的"变美之旅"变成"闹心之旅",消费纠纷主要体现在以下几种情况: 一是预付式消费纠纷,商家以低折扣、充值返现等套路诱导消费者办卡后,可能短期内闭店跑路且拒绝 退费。 二是服务效果与宣传不符,消费者提前约定的造型、款式与实际完成效果差异显著,商家却以个人肤质 或发质问题拒绝整改或退款。 建议消费者理性充值 商家应诚信经营 江苏省消保委建议消费者:1.理性充值:警惕充值返现、终身会员等促销,优先办理小额短期预付卡, 拒绝大额冲动充值。2.明确约定:服务前以图文形式确认款式、价格,拒绝商家模糊承诺。3.核查资 质:选择证照齐全、卫生规范的商家,提前确认产品合规性。 四是产品有卫生隐患,部分商家使用成分不明的美甲胶、睫毛胶,或者工具未按规定一客 ...
12.5亿,2025年美容行业最大收购案
Sou Hu Cai Jing· 2026-01-09 07:07
Core Viewpoint - The acquisition of 100% equity in Shanghai Siyuanli Industrial Co., Ltd. by Meili Tianyuan for 1.25 billion yuan is expected to enhance the group's market position and financial performance, contributing to sustained revenue and profit growth for investors [1][2]. Group 1: Acquisition Details - The acquisition was completed on January 7, 2026, and Siyuanli is now a wholly-owned subsidiary of Meili Tianyuan, with its financial results integrated into the group's consolidated financial statements [1]. - Siyuanli achieved a revenue of 850 million yuan and a net profit of 81 million yuan in 2024, indicating its strong operational performance [2]. - Following the acquisition, the total number of the group's stores has expanded to 734, enhancing its market influence [1]. Group 2: Strategic Synergies - Both Meili Tianyuan and Siyuanli operate in 20 major cities, with over 60% of total revenue coming from first-tier cities like Beijing, Shanghai, Guangzhou, and Shenzhen [2]. - The acquisition will integrate approximately 60,000 direct members from Siyuanli into the group's membership system, resulting in a 44% increase in active membership [2]. Group 3: Future Growth Strategies - The group plans to leverage its experience from the acquisition of the second-largest brand, Nairui, to drive Siyuanli's revenue and efficiency growth through systematic output of medical beauty and sub-health services [3]. - The company aims to implement three major strategies: "super brand," "super chain," and "super digitalization," focusing on personalized customer experiences and operational efficiency [3]. - The introduction of AI capabilities into product innovation is a key aspect of the group's strategy, with plans to launch the "Nairui Intelligent Beauty AI" by 2025 [3].
美丽田园医疗健康(02373.HK)完成收购上海思妍丽实业100%股份
Ge Long Hui· 2026-01-07 13:40
根据股份购买协议,公司已按每股28.71港元的发行价,向SYLHolding配发及发行15,798,147股对价股 份,约占经扩大后已发行股份总数的6.28%。此次MBKPartners通过本次交易对美丽田园进行战略投 资,充分彰显了其对集团业务发展及未来增长潜力的高度认可。 格隆汇1月7日丨美丽田园医疗健康(02373.HK)公告,涉及根据特别授权发行对价股份收购上海思妍丽实 业100%已发行股份。董事会宣布,股份购买协议所载的所有先决条件均已获达成,且交割已于2026年1 月7日根据股份购买协议的条款及条件落实。于交割后及于公告日期,目标公司已成为公司间接全资附 属公司,其经营业绩及财务状况将并入集团综合财务报表。 2024年,上海思妍丽实业实现收入人民币8.5亿元,净利润人民币8,100万元。本次交易完成后,集团门 店网络迅速扩张,总数已达734家。此次扩张不仅推动了集团行业地位与市场影响力提升,也为集团收 入与利润的持续增长注入强劲动力,从而为投资者创造更丰厚的回报。 本次收购是集团继2024年将中国市占率第二大美容服务品牌奈瑞儿纳入麾下后,又一改写行业竞争格局 的关键战略布局。至此,行业前三大品牌齐 ...
瑞丽医美附属拟255万港元认购莱丽医美51.0%股权
Zhi Tong Cai Jing· 2026-01-06 14:46
瑞丽医美(02135)发布公告,于2026年1月6日,缪诗美学、投资者(公司间接非全资附属公司瑞丽美学有 限公司、比夫有限公司)、股东(公司间接全资附属公司瑞丽医疗有限公司、香港翻喜信息服务有限公司) 及目标公司莱丽医美有限公司订立认购协议,缪诗美学及目标公司同意向第一投资者瑞丽美学有限公司 发行合共17万股股份,认购价为255万港元;及缪诗美学及目标公司同意向第二投资者比夫有限公司发行 合共6.33万股股份,认购价为95万港元,惟须受认购协议所载条款及条件规限。完成后,缪诗美学、第 一投资者及第二投资者将分别持有目标公司30.0%、51.0%及19.0%的股份。目标公司将成为公司的间接 非全资附属公司;且目标公司的财务业绩将于完成后并入集团账目。 目标公司(莱丽医美有限公司(前称"缪诗医学美容有限公司"))为一间于香港成立的有限公司。目标公司 尚未开展业务营运,并计划于完成后主要从事提供美容服务及其他相关服务。 董事会认为,认购事项符合集团的业务拓展策略。集团视认购事项为拓展香港业务范围,同时透过于香 港推广品牌及为潜在客户提供美容服务而与其现有业务实现协同效应的独特机遇。董事认为,目标公司 的营运及财务表 ...
古天乐代言的洗脸熊被曝多地门店“跑路”,创始人致歉
Xin Lang Cai Jing· 2026-01-04 07:36
据南方都市报1月3日报道,针对此事,洗脸熊创始人唐华波向南都·湾财社记者表示,对于公司监管不 到位深感自责,将切实维护好消费者的权益。 洗脸熊发布声明称,经核查,此次涉及闭店且未能妥善处理退款事宜的门店,系个别门店在未与总部充 分沟通并违反合作协议的情况下擅自停业所致。目前,洗脸熊全国2600余家门店均正常运营,服务未受 影响。 近日,面部清洁护理品牌"洗脸熊·洗脸吧"(下称洗脸熊)被传多地门店"跑路"。有广东、上海、浙江 等地的消费者投诉 【下载黑猫投诉客户端】称,他们在洗脸熊充值后不久,无法联系上门店,且会员 卡在其他洗脸熊门店无法使用,面临退费难等问题。 声明称,部分个别门店在未与总部充分沟通并违反合作协议的情况下,擅自停业,对此,总部已依据双 方签订的合作协议及国家相关法律法规,启动法律追责程序。企业将持续跟进并公示案件进展,并全力 督促涉事门店完成退款及后续处理工作。 官网资料显示,洗脸熊隶属于广东爱美熊美容科技有限公司,专注面部清洁护理,客户群体为80/90/00 新锐消费者,品牌代言人是演员古天乐。目前,该品牌全球合作门店超过3300家,未来计划开设10000 家。 智通财经查询第三方平台数据发 ...
知名连锁店,多家门店被曝跑路!
Zhong Guo Jing Ji Wang· 2026-01-03 08:44
近日,知名连锁品牌"洗脸熊·洗脸吧"(下称"洗脸熊")被曝多地门店跑路,多位消费者反映,无法联 系上门店,且会员卡在其他洗脸熊门店无法使用。 针对洗脸熊多家门店被曝跑路一事,2025年12月31日,广州市海珠区商务科方面表示,该部门已陆陆续 续收到多起类似的投诉,该部门了解到,洗脸熊以加盟为主,该公司实际上是对品牌进行管理,而对充 值收费这方面的管理并没有统一,海珠区商务科已联系该企业进行沟通。广州市海珠区市场监管局称, 该局已知悉相关情况,并对该公司总部加强监管,如有市场监管领域的违法违规行为将依法依职责查 处。 关注↓↓↓ 天眼查显示,洗脸熊关联企业广东爱美熊美容科技有限公司成立于2021年。截至2025年,洗脸熊在全国 及海外的合作门店数量近3000家。 来源:中国经济网微信综合南方都市报、洗脸熊官网等 针对此事,洗脸熊创始人唐华波向媒体表示,对于公司监管不到位深感自责,将切实维护好消费者的权 益。1月2日,洗脸熊发布正式声明称,部分个别门店在未与总部充分沟通并违反合作协议的情况下,擅 自停业,对此,总部已依据双方签订的合作协议及国家相关法律法规,启动法律追责程序。企业将持续 跟进并公示案件进展,并全力 ...
景顺长城张欢:2026年新消费投资或向两端迁徙
人民财讯12月23日电,在今日由证券时报举办的"攻守之道:新消费高波动背后的定价逻辑重构"沙龙 上,景顺长城研究部基金经理张欢指出,2026年新消费投资或将往"两端"迁移:一是市场需求刚起步、 尚处于早期阶段的品类,包括新功效成分的保健品和口服养生品、医美创新材料、宠物保健品等;其次 是供给释放相对有序,甚至有望出清,供需相对平衡的品类,包括功能性饮料、低糖健康食饮、古法黄 金,以及零食量贩和高端美容服务(中小企业出清)等,其中优选成长确定性高的单品牌或平台型公司。 ...
美丽田园医疗健康(02373.HK)点评:内生+外延双轮驱动 聚焦三大超级战略
Ge Long Hui· 2025-12-19 21:48
Group 1 - The company announced the acquisition of 100% equity in Siyuanli for 1.25 billion RMB (approximately 1.369 billion HKD), aiming to further industry consolidation [1] - Siyuanli, established in 1996, is the third-largest beauty service brand in China, with 182 stores as of June 2024, including 163 beauty stores and 19 medical beauty stores across 48 cities [1] - Post-acquisition, the company's total store count will exceed 700, enhancing market share and accelerating the "Double Beauty + Double Healthcare" strategic layout [1] Group 2 - The company increased its stake in Nairui to 90% after acquiring 70% equity for a total consideration of 350 million RMB, with Nairui being the second-largest traditional beauty service brand in China [2] - In July 2024, the company announced the inclusion of 75 remaining Nairui stores through franchising, adding a total of 150 new stores to its network [2] - Nairui's revenue reached 277 million RMB in the first half of 2025, with adjusted net profit margin improving from 6.5% before acquisition to 10.4% post-acquisition [2] Group 3 - The company held a strategic upgrade conference on November 19, announcing three major strategies: Super Brand, Super Chain, and Super Digitalization [3] - The Super Brand strategy focuses on integrating the top three brands in the industry, including Meili Tianyuan, Nairui, and Siyuanli, to strengthen brand advantages [3] - The company has invested over 200 million RMB in digitalization, achieving double-digit growth in new member acquisition and maintaining a member retention rate of 80% in the following year [3] Group 4 - The company maintains a buy rating, adjusting the 2025 adjusted earnings per share forecast from 1.34 RMB to 1.59 RMB, with new forecasts for 2026 and 2027 set at 2.05 RMB and 2.29 RMB, respectively [3] - The target price has been raised from 19.84 HKD to 37.13 HKD, indicating a potential upside of 41% [3]
美丽田园医疗健康(02373):内生+外延双轮驱动,聚焦三大超级战略
Investment Rating - The report maintains a "Buy" rating for the company, indicating a strong expectation of performance relative to the market [4]. Core Insights - The company is focusing on a dual-driven strategy of organic growth and acquisitions, with a particular emphasis on three major strategic areas: Super Brand, Super Chain, and Super Digitalization [6]. - The acquisition of 100% of the shares of Siyanli for 1.25 billion RMB (approximately 1.369 billion HKD) is expected to enhance market share and accelerate the company's strategic layout [4]. - The company has increased its stake in Nairui to 90%, with significant improvements in operational efficiency post-acquisition, reflected in a rise in adjusted net profit margin from 6.5% to 10.4% [5]. Financial Data and Earnings Forecast - The company forecasts revenue growth from 2,145 million RMB in 2023 to 4,541 million RMB in 2027, with a compound annual growth rate (CAGR) of approximately 31.16% [8]. - Adjusted net profit is projected to increase from 241 million RMB in 2023 to 540 million RMB in 2027, with a notable growth rate of 53.18% in 2023 [8]. - The adjusted earnings per share (EPS) is expected to rise from 1.05 RMB in 2023 to 2.29 RMB in 2027, reflecting a strong upward trend in profitability [8].
奥思集团(01161.HK)年度纯利约8090万港元 同比增长约18.79%
Ge Long Hui· 2025-12-15 11:31
截至2025年9月30日止年度,集团之纯利增加至约8090万港元(2024年:6810万港元)。同比增长约 18.79%。董事会建议派发末期股息每股2.5港仙,全年派息至每股6.0港仙(2024年:5.5港仙)。 格隆汇12月15日丨奥思集团(01161.HK)公告,截至2025年9月30日止年度,集团收益保持稳定,约为 9.81亿港元(2024年:9.83亿港元)。尽管香港零售和经济环境充满挑战,但截至2025年9月30日,集团核 心经营溢利及纯利均有所增加,成为香港美容服务企业中少数几家能持续录得强劲财务表现及按年增长 的上市公司之一。 ...